Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project-Reference-Cited by-同舟云学术

Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Published:2022-10-31 Issue:2 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Campbell Kevin¹,Kao Pei‐Chi¹,Naranjo Arlene²,Kamijo Takehiko³^ORCID,Ramanujachar Ramya⁴,London Wendy B.¹^ORCID,DuBois Steven G.¹^ORCID

Affiliation:

1. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School Boston Massachusetts USA

2. Department of Biostatistics, Children's Oncology Group Statistics and Data Center University of Florida Gainesville Florida USA

3. Research Institute for Clinical Oncology Saitama Cancer Center Saitama Japan

4. Paediatric Oncology University Hospital Southampton NHS Foundation Trust Southampton UK

Funder

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30054

Reference20 articles.

1. SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSIS

2. A proposed staging for children with neuroblastoma.Children's cancer study group A

3. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

4. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

5. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs;Frontiers in Pharmacology;2024-09-04

2. Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531;Pediatric Blood & Cancer;2024-05-31

3. Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services Module;JCO Clinical Cancer Informatics;2024-05

4. Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions;Frontiers in Cell and Developmental Biology;2024-03-27

5. Epidemiological and clinical characteristics of children with peripheral neuroblastic tumors: a study on a Moroccan population;Journal of Cancer Research and Clinical Oncology;2023-11-18